ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      0.00%
      US Tech 100
      19,208.00
      1.04%
      Dow Jones
      40,287.53
      0.00%
      Brent Oil
      81.19
      -1.32%
      Bitcoin
      67,819.38
      -0.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Catalyst Biosciences Inc (CBIO)

      7. Catalyst Biosciences Inc (CBIO) Financials

      Catalyst Biosciences Inc

      Catalyst Biosciences Inc (CBIO)

      Global X China Biotech UCITS ETF USD Acc
      Gx Cn Biotech
      0.5113
      0.00
      (0.00%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      0.5113
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Catalyst Biosciences Inc Financial Summary

      The current CBIO market cap is 19.42M. The company's latest EPS is USD -2.4470 and P/E is -6.20.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 000113.45M27.17M
      Operating Income -4.56M-2.54M-2.82M-53.97M8.07M
      Net Income 260k-2.47M-1.58M-89.15M7.53M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 020.95M7.34M794k113.45M
      Operating Income -57.28M-57.37M-87.89M-65.8M-63.89M
      Net Income -55.18M-56.24M-87.93M-8.24M-92.93M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 18.75M12.39M9.96M116.54M122.01M
      Total Liabilities 11.39M7.4M6.45M38.07M33.24M
      Total Equity -25.95M-28.31M3.52M13.95M88.77M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 98.55M94.85M55.66M28.44M116.54M
      Total Liabilities 30.22M18.78M14.57M16.82M38.07M
      Total Equity 68.34M76.07M41.09M-21.69M13.95M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -6.22M-8.69M-11.9M25.89M2.88M
      Investing 411k5.21M5.21M-19.76M-7.22M
      Financing -7.76M-11.26M-12.74M2.5M658k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -43.61M-55.05M-83.76M-33.1M25.89M
      Investing 27.39M9.66M48.19M55.43M-19.76M
      Financing 327k60.38M49.55M-45.01M2.5M

      Stats and Ratios

      Market Cap 19.42M
      Price to Earnings Ratio -6.20
      Price to Sales Ratio 5.07
      Price to Cash Ratio 17.18
      Price to Book Ratio 7.34
      Dividend Yield -

      Share Statistics

      Shares Outstanding 37.98M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change 18.91%
      52 Week High 0.74
      52 Week Low 0.32
      Spread (Intraday) 0.05 (8.56%)

      Company Info

      Company Name Catalyst Biosciences Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.gyretx.com
      Industry pharmaceutical preparations (2834)